Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder (Q66032018)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder |
clinical trial |
Statements
Duloxetine 60 to 120 mg Once Daily Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder (English)
0 references
January 2005
0 references
380
0 references
18 year
0 references